Abstract:Engineered liver organogenesis is not yet a viable therapeutic option, but ectopic liver histogenesis may be possible. Accumulating evidence has suggested that cell-cell interactions and cell-matrix interactions play an important role in determining the properties of engineered hepatic tissue in vitro and in vivo. In the current study, we utilized heparinized decellularized liver scaffolds and bone marrow mesenchymal stromal cell spheroids to fabricate engineered hepatic tissue, which was subsequently implanted into the omentum of Sprague-Dawley rats with or without liver injury. The survival, liver-specific functions, differentiation level and regenerative potential of the implanted hepatocyte-like cells in this ectopic liver system were evaluated, together with the vascularization status and therapeutic potential of the engineered hepatic tissue. We demonstrated that these hepatic grafts could survive and possess hepatocyte specific function in this ectopic liver system but could also efficiently anastomose with host vascular networks. Furthermore, we found that hepatocyte-like cells within grafts expanded more than 9-fold over the course of 4 weeks in immunocompetent rats with injured livers. Immunostaining revealed that these hepatocyte-like cells could self-organize into cord-like structures in vivo. In addition, these hepatic grafts exhibited therapeutic potential in liver injury induced by CCl<sub>4</sub>. To our knowledge, this is the first report demonstrating the generation of long-term vascularized hepatic parenchyma at ectopic sites based on decellularized liver scaffolds and stem cells. These results provide an economic and feasible method for engineering hepatic tissue from construction to transplantation. This methodology may be applicable in clinical medicine, especially metabolic liver diseases. STATEMENT OF SIGNIFICANCE: In this manuscript, we presented an optimized method for the hepatic engineered tissue (HET) from construction to transplantation. The core of this method is utilizing the combination of heparinized decellularized liver scaffolds and stem cell spheroids, which could provide necessary cell-cell and cell-extracellular matrix interactions for HET in vitro and in vivo. We proved that these hepatic grafts could possess hepatocyte specific function and exhibit strong proliferative activity in ectopic liver system, but also able to anastomose with the host vascular networks efficiently and be compatible with the host immune system. This methodology may be possible one day to apply in clinical medicine, especially metabolic liver diseases.

Polyethylene glycol crosslinked decellularized single liver lobe scaffolds with vascular endothelial growth factor promotes angiogenesis in vivo

Heparin Immobilization Enhances Hemocompatibility, Re-Endothelization, and Angiogenesis of Decellularized Liver Scaffolds

Superior Performance of Co-Cultured Mesenchymal Stem Cells and Hepatocytes in Poly(lactic Acid-Glycolic Acid) Scaffolds for the Treatment of Acute Liver Failure.

Ectopic expansion and vascularization of engineered hepatic tissue based on heparinized acellular liver matrix and mesenchymal stromal cell spheroids

Liver regeneration using decellularized splenic scaffold: a novel approach in tissue engineering

Fabrication of Liver Microtissue with Liver Decellularized Extracellular Matrix (decm) Bioink by Digital Light Processing (DLP) Bioprinting

Enhanced Cellular Function of Human Vascular Endothelial Cell on Poly (Ε-Caprolactone)/gelatin Coaxial-Electrospun Scaffold

Evaluation of Two Decellularization Methods in the Development of a Whole-Organ Decellularized Rat Liver Scaffold.

Dynamic Alterations of Metabolites Revealed the Vascularization Progression of Bioengineered Liver

Promoting endothelialization on decellularized porcine aortic valve by immobilizing branched polyethylene glycolmodified with cyclic-RGD peptide: an in vitro study.

Fibrin Hydrogels for Endothelialized Liver Tissue Engineering with a Predesigned Vascular Network

Functionalized Vascular Structure in Bioengineered Liver Identified with Proteomics

Enhancing small diameter tissue engineered vascular grafts with heparin and hepatocyte growth factor: A promising approach

Strategies for decellularization, re-cellularIzation and crosslinking in liver bioengineering

Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor.

Construction of a biocompatible decellularized porcine hepatic lobe for liver bioengineering

Mesenchymal Stem Cell-Seeded Regenerated Silk Fibroin Complex Matrices for Liver Regeneration in an Animal Model of Acute Liver Failure.

Combining human liver ECM with topographically featured electrospun scaffolds for engineering hepatic microenvironment

The effect of hypoxia-mimicking responses on improving the regeneration of artificial vascular grafts

Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts

Primary human hepatocytes on biodegradable poly(l-lactic acid) matrices: a promising model for improving transplantation efficiency with tissue engineering.